1416710-53-6

Basic information

• Product Name: C₃₃H₅₆N₂O₇SSi₂
• Synonyms: C₃₃H₅₆N₂O₇SSi₂
• CAS NO: 1416710-53-6
• Molecular Weight: 681.054
• Mol File: 1416710-53-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₃₃H₅₆N₂O₇SSi₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₃H₅₆N₂O₇SSi₂(1416710-53-6)
• EPA Substance Registry System: C₃₃H₅₆N₂O₇SSi₂(1416710-53-6)

Safety Data

• Hazardous Substances Data: 1416710-53-6(Hazardous Substances Data)

Upstream product

• 1009816-48-1 (3aR,5R,6S,7R,7aR)-2-(ethylamino)-5-(hydroxymethyl)-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]thiazole-6,7-diol 
• 1382799-64-5 tert-butyl [(3aR,5R,6S,7R,7aR)-6,7-dihydroxy-5-(hydroxymethyl)-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]thiazol-2-yl]ethylcarbamate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1416710-52-5 tert-butyl ((3aR,5R,6R,7R,7aR)-7-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)-6-hydroxy-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]thiazol-2-yl)(ethyl)carbamate 
• 98-88-4 benzoyl chloride 

Relevant articles and documents

SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF

The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.